Los Angeles, United States
Fuse Biotherapeutics, founded in 2021, is a pioneering enterprise in the United States focusing on developing innovative immune-modulating therapeutics targeted at cancer treatment. Their slogan, "Directing and Potentiating our Immune System," reflects their core mission of leveraging the immune system's natural response to effectively combat cancer while ensuring healthy tissues remain unaffected.
Operating at the intersection of Biotechnology, Health Care, Health and Wellness, and Pharmaceutical industries, Fuse Biotherapeutics aims to address complex challenges in oncology with their unique therapeutic approach.
The company's promising trajectory was underscored by a $9.50M Seed Round investment on 15 November 2021. Esteemed investors such as Viva BioInnovator, Sirona Capital, Sherpa Healthcare Partners, GC&H Investments, and Ivy Venture Group recognized the potential of Fuse Biotherapeutics to revolutionize cancer therapy, showcasing strong support for their innovative strategies and growth potential.
